Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sterculia, also known as karaya gum, is a natural polysaccharide obtained from the exudates of trees in the genus *Sterculia* (primarily *Sterculia urens*). It functions as a bulk-forming laxative by acting as a natural fiber that absorbs water in the gastrointestinal tract, significantly increasing in volume to create a soft, bulky stool. This physical expansion stimulates peristalsis, the natural contraction of the intestinal muscles, to promote smooth stool passage without the systemic absorption or chemical irritation associated with stimulant laxatives. Sterculia is primarily used to treat chronic constipation and manage bowel function in patients with hemorrhoids, anal fissures, or those recovering from rectal surgery. Additionally, it is utilized as a pharmaceutical excipient in drug delivery systems for its mucoadhesive and controlled-release properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sterculia.